Karyopharm Therapeutics Inc.
Drug Development Cancer Therapies
- B2B
About Karyopharm Therapeutics Inc.
Develops and commercializes therapies, including XPOVIO, for various cancers by pioneering nuclear export inhibition science, focusing on hematologic and solid tumors.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Newton, Massachusetts, United States
- Founded
- 2008
- Revenue
- $146MFY2025, publicly reported
- Website
- karyopharm.com
- linkedin.com/company/karyopharm
Karyopharm Therapeutics Inc. at a glance
Karyopharm Therapeutics Inc. is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Newton, Massachusetts, United States.
Karyopharm Therapeutics Inc. was founded in 2008.
Karyopharm Therapeutics Inc. has 251–1,000 employees.
Karyopharm Therapeutics Inc.'s revenue is $146M (FY2025, publicly reported).
Frequently asked questions about Karyopharm Therapeutics Inc.
What is Karyopharm Therapeutics Inc.'s revenue?
Karyopharm Therapeutics Inc.'s revenue is $146M (FY2025, publicly reported).
How many employees does Karyopharm Therapeutics Inc. have?
Karyopharm Therapeutics Inc. has 251–1,000 employees.
Where is Karyopharm Therapeutics Inc. headquartered?
Karyopharm Therapeutics Inc. is headquartered in Newton, Massachusetts, United States.
Selling to companies like Karyopharm Therapeutics Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies